The exclusion of people with psychiatric disorders from medical research.

[1]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[2]  Helena Chmura Kraemer,et al.  How Many Subjects? Statistical Power Analysis in Research , 1987 .

[3]  P. Lachenbruch,et al.  Design Sensitivity: Statistical Power for Experimental Research. , 1989 .

[4]  D. Berger,et al.  Averaging Multiple Judges to Improve Validity: Aid to Planning Cost-Effective Clinical Research , 1990 .

[5]  P. Appelbaum,et al.  The MacArthur Treatment Competence Study. III , 1995, Law and human behavior.

[6]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[7]  D Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.

[8]  C. Gross,et al.  Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There? , 2002, Annals of Internal Medicine.

[9]  R. Greenblatt,et al.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols , 2005, AIDS.

[10]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[11]  K. Humphreys,et al.  Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. , 2005, Addiction.

[12]  L. Roberts,et al.  Do research procedures pose relatively greater risk for healthy persons than for persons with schizophrenia? , 2005, Schizophrenia bulletin.

[13]  Alex H. S. Harris,et al.  Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. , 2008, Journal of studies on alcohol and drugs.

[14]  J. Stapleton.  Commentary on Banham & Gilbody (2010): The scandal of smoking and mental illness. , 2010, Addiction.

[15]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[16]  H. Möller,et al.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care , 2011, World psychiatry : official journal of the World Psychiatric Association.

[17]  The Relationship of Adult Mental Disorders to Socioeconomic Status, Race/Ethnicity, Marital Status, and Urbanicity of Residence , 2012 .

[18]  L. Roberts,et al.  Alternative decision-makers' perspectives on assent and dissent for dementia research. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  W. Eaton,et al.  Public Mental Health , 2013 .

[20]  Keith Humphreys,et al.  Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010. , 2013, JAMA internal medicine.

[21]  N. Hoertel,et al.  Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings? , 2014, Journal of clinical psychopharmacology.

[22]  Indicators for Chronic Disease Management of Older Persons , 2014 .

[23]  J. Croft,et al.  Indicators for chronic disease surveillance - United States, 2013. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[24]  K. Humphreys,et al.  A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research , 2015, Tobacco Control.